Immunogenicity 12859
Sample ID
3926
Response
Negative
Tumor Type
Melanoma
Gene Symbol
PSG4
Transcript ID
uc002owb.4
HLA INFO
C*06:02
TCR INFO
No TCR info found!
Full length protein sequence (326 aa)
MGPLS
1
APPCT
6
QRITW
11
KGVLL
16
TASLL
21
NFWNP
26
PTTAQ
31
VTIEA
36
QPPKV
41
SEGKD
46
VLLLV
51
HNLPQ
56
NLAGY
61
IWYKG
66
QMTYL
71
YHYIT
76
SYVVD
81
GQRII
86
YGPAY
91
SGRER
96
VYSNA
101
SLLIQ
106
NVTQE
111
DAGSY
116
TLHII
121
KRRDG
126
TGGVT
131
GHFTF
136
TLHPK
141
LSKPY
146
ITINN
151
LNPRE
156
NKDVL
161
TFTCE
166
PKSKN
171
YTYIW
176
WLNGQ
181
SLPVS
186
PRVKR
191
PIENR
196
ILILP
201
NVTRN
206
ETGPY
211
QCEIR
216
DRYGG
221
IRSDP
226
VTLNV
231
LYGPD
236
LPSIY
241
PSFTY
246
YRSGE
251
NLYLS
256
CFAES
261
NPRAQ
266
YSWTI
271
NGKFQ
276
LSGQK
281
LSIPQ
286
ITTKH
291
SGLYA
296
CSVRN
301
SATGK
306
ESSKS
311
ITVKV
316
SDWIL
321
P
326
Mutation Information
DNA mutation:
None
Peptide Range:
252 ~ 276
Mut AA position:
264 (13 in Wild Type peptide)
Alignment
Wild Type:
"RSGENLYLSCFAESNPRAQYSWTIN
||||||||||||.||||||||||||
Mutant:
RSGENLYLSCFAKSNPRAQYSWTIN"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) PSG4
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay